Return to homepagePandemic Pact

Collaborative project: Early and rapid methods of diagnosis and therapy of viral infections (SARSCoV2Dx)) - Teilvorhaben: COVID-19: Diagnostik, Therapiestrategien & Management

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:15 publications

Grant number: 13N15745

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2026

  • Known Financial Commitments (USD)

    $8,268,480

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    Universitätsklinikum Jena

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

15 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Subacute Bartonella quintana bacteremia following immunomodulatory therapy: a diagnostic challenge.

The human lung microbiome progressively diminishes in the distal alveolar regions.

Slimformer: An NLP-based web server for semantic categorization of gene sets.

Nbeal2 Inactivation Triggers Abl1 Stabilisation and Dysregulated Subcellular Localisation of the Multi-Drug-Resistant Protein MDR1 (ABCB1) in Mast Cells.

Raman Spectroscopy Can Identify Acute and Persistent Biochemical Changes in Leukocytes From Patients With COVID-19 and Non-COVID-19-Associated Sepsis.

Age- and sex-associated differences in immune cell populations.

Leveraging mobility data to analyze persistent SARS-CoV-2 mutations and inform targeted genomic surveillance.

Evaluating the potential of vancomycin-modified magnetic beads as a tool for sample preparation in diagnostic assays.

SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells.